Migraine affects roughly one billion people worldwide, yet most of them never get a structured diagnosis or a coordinated care plan. Hemi Health, a migraine care startup from Denmark, is building exactly that – and the startup closed a €4 million seed round to prove the model works beyond Denmark.
The round was led by Denmark’s Export and Investment Fund (EIFO) and Swiss Health Ventures, with continued backing from Sondo Capital, Alliance Venture Capital, and Crowberry Capital. The Netherlands is the first international market on the roadmap.
Founded in 2023:
Hemi Health was founded in 2023 by Benedicte Grytte Dahl, Anna Løfqvist, Sune K-Holm Nielsen, and Mathias Iversen. The team built the company around a problem they experienced firsthand. Co-founder Anna Løfqvist notes that she lives with migraine herself and knows how exhausting fragmented care pathways can be. That personal context shapes the product’s direction.
Originally focused on migraine and headache, the company expanded into concussion care earlier than planned as demand exceeded expectations. It now also treats whiplash.
How the Model Works:
Hemi operates a hybrid care model – physical clinics in Frederiksberg, Middelfart, and Aarhus, plus a fully digital layer. Through the HEMI app, patients connect with specialists via video consultations and record symptoms in a digital diary. No referral is needed to book.
Each patient gets a mapped diagnosis and a personalized treatment plan built by a specialist with at least 15 years of experience. The plan lives in the app, and patients can message their care team directly between appointments. It’s a structured, multidisciplinary pathway – not a one-off consultation.
The company cooperates with several insurance companies, and also accepts self-paying patients and public referrals through Denmark’s extended free hospital choice scheme. That three-channel payment structure broadens the addressable base significantly.
1,000 Patients and Growing:
Hemi Health has helped more than 1,000 people with migraines, headaches, and concussions through its structured, multidisciplinary treatment model. For a company founded in 2023, that’s meaningful early traction in a specialty that is chronically underserved.
Nearly 80% of Hemi’s patients are women – a stat that reflects the broader reality of migraine, which disproportionately affects women of working age. Hemi’s patient mix makes it a de facto women’s health platform, even if that isn’t its primary framing.
The AI Layer:
A major portion of the €4 million goes toward developing Hemi’s proprietary digital platform further. CTO Mathias Buch Iversen describes the potential of AI in complex care as substantial – able to transform multi-year fragmented journeys into structured programs with clear progression and measurable outcomes.
That’s a practical framing of AI’s role: not replacing clinicians, but organizing care data in ways that make long-term management of chronic conditions more consistent and trackable. For insurers and public health systems focused on outcomes, that’s a compelling value proposition.
Netherlands Expansion:
The company sees strong alignment with insurance-driven systems where structured, outcome-oriented care pathways are in demand. The Netherlands fits that profile – it has a mixed public-private insurance system and a relatively mature digital health adoption curve.
Expanding into a new country in healthcare requires navigating different reimbursement rules, clinical regulations, and language requirements. Hemi’s digital-first setup lowers some of those friction points, and its insurance partnerships in Denmark give it a template to replicate.
Why this Matters Now:
Migraine and post-concussion care represent a large, measurable gap in European healthcare. Most patients cycle through general practitioners without access to multidisciplinary neurology expertise. Hemi’s model routes them directly to specialists, creates a structured care record, and keeps them engaged through an app rather than letting them fall out of the system between appointments.
For health systems under cost pressure, paying for structured, outcomes-tracked specialty care is often cheaper than repeated emergency or GP visits with no coordinated follow-up. That’s the structural argument that makes Hemi worth watching as it scales.
If you’re building in digital health or exploring structured chronic care pathways, Hemi Health’s approach to migraine and concussion treatment offers a clear example of how specialty care can be made accessible and trackable at scale.
